XU Hu, WANG Feng. Clinical value of tumor type M2 pyruvate kinase as a tumor marker in diagnosis of breast cancer[J]. Journal of Clinical Medicine in Practice, 2011, (3): 99-100,103. DOI: 10.3969/j.issn.1672-2353.2011.03.034
|
Citation:
|
XU Hu, WANG Feng. Clinical value of tumor type M2 pyruvate kinase as a tumor marker in diagnosis of breast cancer[J]. Journal of Clinical Medicine in Practice, 2011, (3): 99-100,103. DOI: 10.3969/j.issn.1672-2353.2011.03.034
|
XU Hu, WANG Feng. Clinical value of tumor type M2 pyruvate kinase as a tumor marker in diagnosis of breast cancer[J]. Journal of Clinical Medicine in Practice, 2011, (3): 99-100,103. DOI: 10.3969/j.issn.1672-2353.2011.03.034
|
Citation:
|
XU Hu, WANG Feng. Clinical value of tumor type M2 pyruvate kinase as a tumor marker in diagnosis of breast cancer[J]. Journal of Clinical Medicine in Practice, 2011, (3): 99-100,103. DOI: 10.3969/j.issn.1672-2353.2011.03.034
|
DownLoad: